Ownership history in Bayesian Capital Management, LP · 22 quarters on record
This page tracks every 13F SEC filing in which Bayesian Capital Management, LP reported a position in RESMED INC (RMD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 2,816 | -14,500 | -83.7% | 0.16% | $771K | $272.45 |
| 2025 Q2 | REDUCED | 17,316 | -4,784 | -21.6% | 0.71% | $4.5M | $256.26 |
| 2024 Q4 | ADDED | 22,100 | +14,300 | +183.3% | 0.62% | $5.1M | $226.15 |
| 2024 Q3 | REDUCED | 7,800 | -6,365 | -44.9% | 0.22% | $1.9M | $240.88 |
| 2024 Q2 | ADDED | 14,165 | +5,200 | +58.0% | 0.31% | $2.7M | $188.43 |
| 2024 Q1 | ADDED | 8,965 | +4,700 | +110.2% | 0.17% | $1.8M | $194.51 |
| 2023 Q4 | ADDED | 4,265 | +2,493 | +140.7% | 0.08% | $734K | $168.53 |
| 2023 Q1 | REDUCED | 1,772 | -715 | -28.7% | 0.05% | $388K | $212.90 |
| 2022 Q3 | ADDED | 2,487 | +1,400 | +128.8% | 0.11% | $543K | $211.38 |
| 2022 Q2 | REDUCED | 1,087 | -354 | -24.6% | 0.04% | $228K | $202.60 |
As of 2025 Q4 — sorted by position size